Transcatheter aortic heart valve replacement device data presented at this year's American College of Cardiology Scientific Sessions support an accelerated development path for the next-generation Sapien device and expanded application of the technology to less acutely sick patients, TAVR researchers suggest.
Meanwhile, researchers tied to Medtronic PLC say data may now supports a change in clinical guidelines to